Publications by authors named "Matthew N Brams"

Claim this Profile
S
Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.
Andrew J Cutler, Scott H Kollins, Matthew N Brams, Meg Corliss, Charles Oh

Front Psychiatry· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.
Ann C Childress, Andrea Marraffino, Andrew J Cutler, Charles Oh, Matthew N Brams

J Child Adolesc Psychopharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia.
Richard Jackson, Matthew N Brams, Noelle E Carlozzi, Leslie Citrome, Nora E Fritz

J Clin Psychiatry· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.
Scott H Kollins, Rene Braeckman, Sven Guenther, Andrew C Barrett, Travis C Mickle, Matthew N Brams

J Child Adolesc Psychopharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations.
Richard Jackson, Matthew N Brams, Leslie Citrome, Amber R Hoberg, Stuart H Isaacson

Neuropsychiatr Dis Treat· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.
Ann C Childress, Matthew N Brams, Andrew J Cutler, Graeme A E Donnelly, Sailaja Bhaskar

J Child Adolesc Psychopharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
Ann C Childress, Sharon B Wigal, Matthew N Brams, John M Turnbow, Yulia Pincus

J Child Adolesc Psychopharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis